Pioneer of InsurTech in Europe, Qover raises €20M to accelerate its global growth: insights from Quentin Colmant, Jean-Charles Velge & their partner at Alven Rodolphe Menegaux
Ahead of Qover’s announcement of its €20m Series B round, we sat down with Qover’s co-founders Quentin Colmant, Jean-Charles Velge and Alven Partner Rodolphe Menegaux, to get their thoughts on Qover, its exciting prospects for the future and its journey since joining the Alven portfolio in 2019.
In this exchange, Quentin, Jean-Charles & Rodolphe discussed:
00:08 – Who are they
00:11 – What is Qover
01:25 – Key figures about Qover
02:35 – What makes Qover different
03:50 – The big challenge to come
05:09 – Why a B2B2C model?
06:09 – Qover’s ambitions
06:43 – Investing in Qover: insights from Rodolphe
07:27 – Working with Alven
08:24 – Founders’ Corner: Advice from Quentin and Jean-Charles to his founder peers
Oversubscribed round led by Picus Capital and Alven will fast-track clinical validation of AI-based Cancer- Biomarker Platform Polaris™, expand global reach, and…